Lung Cancer Screening Adherence Among People with HIV Treated at an Integrated Health System in Florida

AIDS Res Hum Retroviruses. 2023 Sep;39(9):482-484. doi: 10.1089/AID.2022.0158. Epub 2023 Jun 22.

Abstract

We evaluated low-dose computed tomography (LDCT) adherence among people with HIV (PWH) treated at University of Florida (UF). From the UF Health Integrated Data Repository, we identified PWH who underwent at least one LDCT procedure (January 1, 2012-October 31, 2021). Lung cancer screening adherence was defined as having a second LDCT within recommended observation window, based on the Lung Imaging Reporting and Data System (Lung-RADS®). We identified 73 PWH with a history of at least one LDCT. PWH were mostly male (66%), non-Hispanic Black (53%), and living in urban (86%), high poverty (45%) areas. Almost 1 in 10 of PWH were diagnosed with lung cancer after their first LDCT. Overall, 48% and 41% of PWH were diagnosed with Lung-RADS categories 1 and 2, respectively. We observed that 12% of PWH were adherent to LDCT. Only 25% of PWH diagnosed with category 4A were adherent. PWH may have poor adherence to lung cancer screening.

Keywords: HIV-positive adults; LDCT; aging; cancer prevention; lung cancer screening; people living with HIV.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Delivery of Health Care, Integrated*
  • Early Detection of Cancer / methods
  • Female
  • Florida / epidemiology
  • HIV Infections* / complications
  • Humans
  • Lung Neoplasms* / diagnosis
  • Male
  • Mass Screening / methods
  • Tomography, X-Ray Computed / methods